Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms. RoosterBio to leverage scalable, continuous…
Super UserJanuary 24, 2022
So, you just had a $5 billion venture capital year. Now what? With the final numbers for Q4 finally in,…
Super UserJanuary 24, 2022
A life sciences building in downtown Bethesda seemed like a slam dunk when StonebridgeCarras and Donohoe Cos. first proposed it…
Super UserJanuary 24, 2022
The University of Maryland has again ranked among the top 10 research institutions in the National Science Foundation’s (NSF) Higher…
Super UserJanuary 24, 2022
Center will expand Orgenesis’ Point of Care (POCare) Platform Capabilities in Maryland GERMANTOWN, Md., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Orgenesis…
Super UserJanuary 18, 2022
Wednesday, February 02, 2022, 12:00pm - 01:30pm Winning over a hospital Value Analysis Committee or “VAC” is a must for companies targeting hospital…
Super UserJanuary 18, 2022
Jonny’s back! Despite the continuation of COVID -19 through 2021, 2021 was a spectacular year for venture fundraising. Investment in…
Super UserJanuary 18, 2022
The Developing and Accelerating Age-Tech and Digital Health Solutions webinar series, hosted by NIA’s Small Business Program, offers research entrepreneurs…
Super UserJanuary 18, 2022
One month after being acquired in a $40 million deal by U.K.-based Vaccitech plc, the team that was formerly part…
Super UserJanuary 18, 2022